Guangdong Pharmaceutical conducts training to strengthen awareness of fair trade for executives and employees
Jun 12, 2025
|
The training site, which was designed to strengthen self-compliance with fair trade through lectures by legal professionals specializing in fair trade laws and to strengthen the ability to prevent and respond to risks of violations of fair trade laws, was attended by Chairman Choi Sung-won of Kwangdong Pharmaceutical, head of each division, team leader level or higher, executives and staff members of Kwangdong Pharmaceutical's Anti-Corruption Subcommittee.
In addition, evaluation training and practice were conducted through external professional consultants to prevent the risk of fair trade compliance programs (CP) and legal violations. Employees had time to analyze cases of violations of the Fair Trade Act and prepare a list of reviews that could occur in practice. In addition, compliance training was also conducted to raise the level of recognition of fair trade, such as ▲ compliance with laws ▲ compliance monitoring ▲ internal control.
Meanwhile, Kwangdong Pharmaceutical introduced a fair trade compliance program (CP) in January to further strengthen ethical management. In addition, in 2023, it acquired the Anti-Corruption Management System (ISO 37001) and the Compliance Management System (ISO 37301).
Chairman Choi Sung-won said, "Activities for establishing a fair trade culture are indispensable elements to become a 'trusted company' pursued by Kwangdong Pharmaceutical beyond mere compliance with the law. We will continue to conduct more systematic and practical fair trade activities through effective education in the future."
This article was translated by Naver AI translator.
